Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 14/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25992017 | 0.90 | GRM5 (0.43) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25991989 | 0.86 | ADORA1 (0.38) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25991965 | 0.85 | TRPV4 (0.45) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25992015 | 0.78 | ADORA1 (0.41) | ADORA1ADORA2AADORA2B | |
| SCHEMBL15298292 | 0.74 | ADORA1 (0.54) | ADORA1ADORA2AADORA2BKDM4EMEN1 | |
| SCHEMBL25992004 | 0.73 | TRPV4 (0.36) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25992019 | 0.73 | ADORA2A (0.38) | ADORA1ADORA2A | |
| SCHEMBL25992003 | 0.72 | KHK (0.36) | ADORA1ADORA2AADORA2BKDM4E | |
| SCHEMBL25991975 | 0.70 | ADORA1 (0.35) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25992384 | 0.70 | XDH (0.46) | ADORA1ADORA2AADORA2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, CRY1, CRY2 | ADORA1 3376/4885ADORA2A 1718/4885ADORA2B 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.